chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2nd booster of Moderna COVID-19 Vaccine, administered 05/18/2022  5/18 Wednesday, within 2 hours I had swelling and pain in the arm, left leg started swelling  5/22 Sunday, the leg was very large and hard as a rock  5/23 Monday, ultrasound showed extensive blood clots in left leg from crotch to knee  5/23 Monday, Ct Scan showed many blood clots in lungs  5/23 Monday, admitted to ER   5/24 Tuesday, admitted to hospital   5/25 Thursday afternoon, left hospital with oxygen tank  5/25 in home oxygen system delivered and installed
Sunday morning 20SEP98 started w/flat red pinpoint ladybug size rash;no itching on feet progressed up rt leg to buttocks;no fever;has cough & runny nose & pulling on lt ear;c/o ear pain;referred to MD for eval;
Pt recvd vax MAY92 & several days following vax devel generalized malaise, joint pains, sensation of bumps along the bones of arms;
elevated blood cell count; This case was reported by a consumer via other manufacturer and described the occurrence of white blood cell count increased in a 6-month-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   On 7th January 2021, the patient received Influenza vaccine Quadrivalent 2020-2021 season. On 7th January 2021, unknown after receiving Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced white blood cell count increased. On an unknown date, the outcome of the white blood cell count increased was unknown.   It was unknown if the reporter considered the white blood cell count increased to be related to Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were reported as follows: The reporter reported that, the patient received her flu shot and experienced white blood cell count was elevated. No lot or expiration date was known. The reporter denied for consent follow up. Note- The patient's date of birth is mentioned and vaccination date was provided as 7th Jan 2020 which seems discrepant. Therefore the date of vaccination was 7th Jan 2021 conservatively.; Sender's Comments: T202005981:
Patient brought to ER with cardiac arrest.  At home woke up to go to bathroom was wheezing and collapsed (family report).
first night paralyzed left arm at injection site, intense pain, swollen. Second day could raise arm parallel to body, 99.8 fever, exhaustion, headaches, loss of appetite. Third day arm could be raised in front of body, fever gone, rest remained, left arm swollen, rose-colored and mild, irritating itching by nightfall. Fourth day, arm rather mobile, somewhat less itching and swelling on upper arm, other reactions gone. No treatment.
Immediately after receiving vaccines, c/o generalized weakness, color pale, ringing in ear.  Child did not lose consciousness, vital signs remained stable; monitored, left office without further concerns.  Child returned to office 9/23/08 with c/o chest pain, sore throat, slight dizziness, difficulty swallowing - Evaluated by physician again on 9/29/08, all symptoms resolved.
arm is swollen; arm is tender; arm is warm to the touch; headache; throbbing in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (throbbing in her left arm), PERIPHERAL SWELLING (arm is swollen), TENDERNESS (arm is tender), VACCINATION SITE WARMTH (arm is warm to the touch) and HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN (throbbing in her left arm) and HEADACHE (headache). On 29-Jan-2021, the patient experienced PERIPHERAL SWELLING (arm is swollen), TENDERNESS (arm is tender) and VACCINATION SITE WARMTH (arm is warm to the touch). At the time of the report, PAIN (throbbing in her left arm), PERIPHERAL SWELLING (arm is swollen), TENDERNESS (arm is tender), VACCINATION SITE WARMTH (arm is warm to the touch) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Cold compress for treatment.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. An 81-year-old male patient received BNT162b2 (BNT162B2), on 05Apr2022 as dose 4 (booster), single (Lot number: FK9825) at the age of 80 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "Prostate surgery", start date: 2017 (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: COVID-19: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti-viral treatment included Paxlovid.
Reported today a local reaction at injection site. Described 5" swelling, painful & warm to touch. Taking BENEDRYL po. Today reports less swelling - 2" - less discomfort. 1-22-2010 Reported fever 100.8 degrees.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 8/22/2022,  9/5/2022,  9/20/2022,  10/3/2022,  10/18/2022,  10/24/2022 -- RECURRENCE OF SAME SYMPTOMS
FLARE UP ON HIS LOWER BACK/SEVERE LOWER BACK PAIN,LEFT LUMBAR SIDE; LEGS HURTING; FELT QUITE TIRED; This spontaneous report received from a patient concerned a 36 year old male. The patient's weight was 85 kilograms, and height was 186 centimeters. The patient's concurrent conditions included non smoker, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported,  batch number: 201A21A, expiry: 07-AUG-2021) dose was not reported, administered on 22-JUN-2021 15:14 for prophylactic vaccination. No concomitant medications were reported. On 23-JUN-2021, the subject experienced flare up on his lower back/severe lower back pain, left lumbar side. On 23-JUN-2021, the subject experienced legs hurting. On 23-JUN-2021, the subject experienced felt quite tired. Treatment medications included: naproxen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from flare up on his lower back/severe lower back pain, left lumbar side, felt quite tired, and legs hurting. This report was non-serious.
Received Pneumovax approx 10:00 am, by 12:30 pm she noticed swelling, hotness, redness, pain and itching in left arm, fingers, breast area and into neck.  Has gotten worse in pas 24 hours; has tried Aleve (Advil) with some relief.  Dr. recommends by phone to taken Benadryl 25-50 mg every 6 hours as needed. To follow up if not better in 2 days or gets worse.
No adverse event. Wrong Covid 19 vaccine was given for second dose.  Pfizer was initially given on 3/26/21 at a different location.  The second dose was given on 4/15/21 with Moderna.
Broken of the right eye vein that led to bleeding; excruciating pain (like a labor pain; Diarrhea; vaginal bleeding; Dizziness; Stomach Cramping; A spontaneous report was received from a consumer who was also a 82-years-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and who experienced:  excruciating pain - like a labor pain (pain), stomach cramping (abdominal pain upper), diarrhea, vaginal bleeding (vaginal haemorrhage), dizziness and broken of the right eye vein that led to bleeding (eye haemorrhage).   The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included: methotrexate.   On 22Jan2021, the patient received their first of two planned doses of Moderna's COVD-19 Vaccine (mRNA-1273, lot number: not provided) intramuscularly for prophylaxis of COVID-19 infection.  Later on 22Jan2021, the patient began to develop: excruciating pain - like a labor pain (pain), diarrhea, vaginal bleeding (vaginal haemorrhage), dizziness and broken of the right eye vein that led to bleeding (eye haemorrhage).  She reports these events lasted for 1 day and then stopped. The patient states she still experiences stomach cramping (abdominal pain upper), The patient confirmed she consulted with her physician and blood work was done. The results of the blood work were not provided.   No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported. Patient is wondering if these events are normal and if she should receive her second dose.   The outcome of the events: excruciating pain - like a labor pain (pain), diarrhea, vaginal bleeding (vaginal haemorthage), dizziness and broken of the right eye vein that led to bleeding (eye haemorrhage) is considered to be resolved based on patient reported duration of 1 day. The outcome of event: stomaching cramping (abdominal pain upper) is considered not recovered/not resolved per patient report.; Reporter's Comments: This case concerns a 82-years-old, female patient who experienced:  excruciating pain- like a labor pain, abdominal pain upper, diarrhea, vaginal bleeding, dizziness and eye haemorrhage.  Very limited information regarding this events has been provided at this time.  Further information has been requested.
Mother reported "high fever" (did not take temp) and that he was "acting inappropriately".
A day after receiving the vaccine she had the flu, major headaches, bones were hurting badly, joint started to swell over a week of trying to take Tylenol the symptoms got worst whole body was hurting and could barely stand. Visited the hospital a week and half later because her legs got numb; could barely walk. Pain lasted two weeks even after receiving the vaccine. Kept having fevers at a extremely high temperatures.
Covid vaccine issue/fatigue; Sore arm; Redness at injection site; Itchiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Covid vaccine issue/fatigue), VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (Itchiness at injection site) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Panuveitis.    Concurrent medical conditions included Panuveitis (non-infectious intermediate, posterior and panuveitis).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jul-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, the patient experienced FATIGUE (Covid vaccine issue/fatigue), VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (Itchiness at injection site). At the time of the report, FATIGUE (Covid vaccine issue/fatigue), VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (Itchiness at injection site) outcome was unknown.     No concomitant medications were reported. It was unknown if patient was enrolled in a COVID-19 vaccine trial. On 02-Jul-2022, patient took booster dose.  The reporter causality of events with Humira was not provided. No treatment drugs were reported.
Diarrhea; Worsening of Shortness of Breath; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DYSPNOEA (Worsening of Shortness of Breath), FATIGUE (Fatigue) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031821A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (She said she had Covid at the end of December and was very sick and this feels a little like it but not as bad.). Concurrent medical conditions included Heart disorder (she has a heart condition and does suffer from shortness of breath).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced DIARRHOEA (Diarrhea), DYSPNOEA (Worsening of Shortness of Breath), FATIGUE (Fatigue) and CHILLS (Chills). At the time of the report, DIARRHOEA (Diarrhea), DYSPNOEA (Worsening of Shortness of Breath), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Mild Flu like symptoms and body aches that did not go away. Nodule in forearm near elbow on the left arm that radiated pain up and down my arm appeared and went in the ER to have it checked. 04/26/2021 EKG, Ultrasound, X-ray, physical, and blood work. No treatment given but have recovered from adverse event.
After the first pill, my stomach was a little upset. A few hours after the second pill (taken 23 Dec 2017 at 8am), I started to feel symptoms similar to a urinary tract infection: burning on urination, frequent urge to urinate, abdominal pain. I treated with plenty of juice and water. I noticed some blood spotting in the late afternoon. It progressively increased. By midnight I was in horrible pain and there were copious amounts of blood in my urine. I decided to ride it out at home rather than going to the ER where I wouldn't be in the comfortable and familiar surroundings of my home. By morning, the blood began to subside. The intense abdominal pain continued several hours. The burning and pain on urination continued until Jan 10, 2018, gradually decreasing daily. I took the third dose on Dec 25, 2017 at 8am. I started to feel achy all over around 1030 am. I ran a fever of 99-100 and had some constipation. I took the fourth dose with no further symptoms. On Jan 2, 2018 I noticed dark brown spots on my teeth which went away a week later.
This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 15-JUN-2015, the patient was vaccinated with an improperly stored dose of VAQTA 10 Pk 25U/0.5 ml SD Llok w Cap Ped, which had the lot # L001445, with expiration date 15-FEB-2016 (dose, dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On an unspecified date the vaccine experienced a temperature excursions of 24 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius degree). The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator (R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Patient felt like her throat was scratchy, she later developed night sweats, transient numbness / tingling in her extremities, and POTS
Syncope.  Pt. received vaccinations with TdaP & Influenza.  Shots L arm each separated by ~15 seconds, then received Menactra R arm & no problems, 4th vaccine Gardasil R arm.  Pt had pain with RUSH up arm & within seconds of shot fell off exam table to R side striking R frontal parietal area and few seconds LOC with vagal type appearance.
This spontaneous report was received from a physician, via a company representative, concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 09-SEP-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with lot # L007720 Expiration date: 08-JUL-2016, 0.5 ml (route and anatomical location of administration were not reported). The sum hours in excursion was 72 hours and the lowest recorded temperature reported was 33 Fahrenheit (F) (0.555555556 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor Product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
I started getting symptom of nasal congestion and runny nose that continued for 2 days. I took an at home COVID-19 test that was positive. I started experiencing a cough, headache, fatigue, and slight fever. On the 4th day I started getting diarrhea. I done a telehealth visit with my doctor on 5/5/2022 and was prescribed Paxlovid. After taking Paxlovid my symptoms had cleared by 5/7/2022. I still have some nasal congestion but that is common for me.
my right arm went numb like it went to sleep; a fewsharp pains in fingers went away, odd shooting pain in my right fingers comes and goes as well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 29Aug2021 13:00 (Lot number: BC3180) at the age of 49 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 01, Lot  number: EW0191, Administration time: 01:00 PM, Vaccine Location: Left arm), administration date: 03Aug2021, when the patient was 49 years old, for Covid-19 Immunization. The following information was reported: VACCINATION SITE HYPOAESTHESIA (non-serious) with onset 29Aug2021 13:15, outcome "not recovered", described as "my right arm went numb like it went to sleep"; PAIN IN EXTREMITY (non-serious) with onset 29Aug2021 13:15, outcome "not recovered", described as "a fewsharp pains in fingers went away, odd shooting pain in my right fingers comes and goes as well". Therapeutic measures were not taken as a result of vaccination site hypoaesthesia, pain in extremity.  Additional information: Patient has no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. It was reported that minutes after the shot was given half of patient's right arm went numb like it went to sleep, a few sharp pains in fingers went away. The numbness kept coming and going and the odd shooting pain in her right fingers comes and goes as well. Sometimes together sometimes not and only in the right arm. Patient was hoping it would go away but it continued and was annoying. Events did not result to both emergency room visit and physician office visit.  No follow-up attempts are possible. No further information is expected.
large, intensely itchy. injection site; painful swelling of the injection site; painful swelling of the injection site; headache; nausea; dizziness; significant joint pain.; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 67-year-old female patient (not pregnant) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 12Jul2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 67 years, in left deltoid for immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "latex" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; PROMETRIUM [PROGESTERONE]; ESTRADIOL. Past drug history included: Clindamycin, reaction(s): "Drug Allergy: Clindamycin"; Ampicillin, reaction(s): "Drug Allergy: ampicillin". The following information was reported: DIZZINESS (non-serious) with onset 16Jul2023, outcome "recovered"; HEADACHE (non-serious) with onset 16Jul2023, outcome "recovered"; NAUSEA (non-serious) with onset 16Jul2023, outcome "recovered"; ARTHRALGIA (non-serious) with onset 16Jul2023, outcome "recovered", described as "significant joint pain."; VACCINATION SITE PRURITUS (non-serious) with onset 19Jul2023, outcome "recovered", described as "large, intensely itchy. injection site"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 19Jul2023, outcome "recovered" and all described as "painful swelling of the injection site". Therapeutic measures were not taken as a result of headache, nausea, dizziness, arthralgia, vaccination site pruritus, vaccination site pain, vaccination site swelling. Additional information: No other vaccine used in same date or in four weeks.  The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
black speck floating in the vial; This spontaneous case was reported by a pharmacist and describes the occurrence of LIQUID PRODUCT PHYSICAL ISSUE (black speck floating in the vial) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced LIQUID PRODUCT PHYSICAL ISSUE (black speck floating in the vial). At the time of the report, LIQUID PRODUCT PHYSICAL ISSUE (black speck floating in the vial) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 22-SEP-2014, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX (dose number and route were not reported), 0.5 ml, lot # K005182, expiration date 10-APR-2014 for vaccination. Co-suspect and concomitant therapies were not reported. The registered nurse reported the 26 patients received doses of (Oka/Merck) VARIVAX (from lot # K005182, expiration date 10-APR-201 only) that were improperly. No adverse effect reported for any of the patients. This is one (1) of twenty seven (27) reports from the same reporter. Additional information has been requested.